Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Joey CohenMedication Adherence
Daniel SontupeMarket Access
Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
EXPAND shows oral siponimod (BAF312) is the first potential therapy to meaningfully delay disability ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email